LifeCycle Pharma's Financial Calendar 2008

Print
| Source: Veloxis Pharmaceuticals A/S
multilang-release
Company Announcement no. 03/2008                                                
To: OMX Nordic Exchange Copenhagen		            Hørsholm, Denmark, January 31,  
2008                                                                            

                                                                                
                  LifeCycle Pharma's Financial Calendar 2008                    
                                                                                
Hørsholm, Denmark, January 31, 2008; LifeCycle Pharma A/S (OMX: LCP), an        
emerging specialty pharmaceuticals company, hereby issue its Financial Calendar 
2008:                                                                           

--------------------------------------------------------------------------------
| Date                | Event                                                  |
--------------------------------------------------------------------------------
| 28 February 2008    | Financial Statements for the Full Year 2007            |
--------------------------------------------------------------------------------
| 7 April 2008        | Publication of Annual Report 2007                      |
--------------------------------------------------------------------------------
| 24 April 2008       | Annual General Meeting                                 |
--------------------------------------------------------------------------------
| 14 May 2008         | Interim Financial Statements for the period ending 31  |
|                     | March 2008                                             |
--------------------------------------------------------------------------------
| 27 August 2008      | Interim Financial Statements for the period ending 30  |
|                     | June 2008                                              |
--------------------------------------------------------------------------------
| 26 November 2008    | Interim Financial Statements for the period ending 30  |
|                     | September 2008                                         |
--------------------------------------------------------------------------------


About LifeCycle Pharma A/S (“LCP”)                                              
LCP is an emerging specialty pharmaceuticals company that, through innovative   
technologies, is able to rapidly develop a portfolio of differentiated products 
to meet the unique needs of key therapeutic markets and patient populations.    
This includes products for immunosuppression, specifically organ                
transplantation, and to combat certain cardiovascular diseases.  By using its   
unique and patented delivery technology, MeltDose®, LCP is able to develop drugs
with enhanced absorption and thereby increased bioavailability. Currently, the  
Company has a diversified near- and medium-term pipeline, including a product   
ready for US commercialization, five product candidates in clinical trials and  
three in preclinical stages of development. LCP is listed on the OMX Nordic     
Exchange under the trading symbol (OMX: LCP). For further information, please   
visit www.lcpharma.com.                                                         


For further information please contact LifeCycle Pharma A/S:                    
--------------------------------------------------------------------------------
| Flemming Ornskov, MD           |                                             |
| President and CEO              |                                             |
| +45 2420 0368; FO@lcpharma.com |                                             |
--------------------------------------------------------------------------------